期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 609, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2021.121148
关键词
Synthesis; Acetyl carnitine; Cholesterol; Liposome surface modification; Cell uptake; Cancer therapy
资金
- Research Council of Tabriz University of Medical Sciences
- Faculty of Pharmacy, Tabriz University of Medical Sciences, Iran [136]
The study successfully synthesized CAC and surface-modified PEGylated liposomes to enhance cancer cell uptake. The CAC + PEG-modified liposomes showed the best cellular uptake and low cytotoxicity at commonly applied concentrations. The results suggest that the organic cation transporter, cationic structure, and metabolic preference of CAC may contribute to the increased cellular uptake in cancer cells.
The present study aimed to synthesize cholesteryl acetyl carnitine (CAC), and surface modify the PEGylated liposomes with the intention of enhanced cancer cell uptake. For this, CAC synthesis was performed in amine-free esterification conditions and then four liposomal formulations of unmodified, CAC/PEG, and CAC + PEGmodified were prepared by ethanol injection method. Cytotoxicity of the liposomes was investigated in A549 cells, followed by cellular uptake assessments of coumarin 6 (C6)-loaded liposomes. The results of ATR-FTIR, 1HNMR, and 13CNMR demonstrated successful formation of CAC. A molecular docking study showed efficient binding affinities rather than carnitine to the active site of four carnitine transporters. Liposomal formulations possessed spherical morphology with a mean particle size range of 112-138 nm, narrow size distribution, and negative surface charge. All formulations had low cytotoxicity at 0.5 mg/ml, but high cytotoxicity at around 2.5 mg/ml. The lowest IC50 was obtained for CAC modified liposomes. CAC + PEG-modified liposomes had the highest cellular uptake. In conclusion, CAC + PEG modification of liposomes is an effective approach for increasing A549 cellular uptake, with low cytotoxicity at commonly applied liposome concentrations. The elevated uptake may be due to the involvement of the organic cation transporter, cationic structure, and the metabolic preference of CAC in cancer cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据